[Ip-health] WHO prequalifies first generic hepatitis C medicine and first HIV self-test

BAGOZZI, Daniela bagozzid at who.int
Fri Jul 21 07:10:03 PDT 2017


 
In the lead-up to the Paris AIDS Conference and World Hepatitis Day, WHO has prequalified two priority products to tackle both HIV and hepatitis C.  The first WHO-listed generic sofosbuvir could extend treatment for this major disease to many more patients.  And the first WHO-prequalified HIV self-test will improve diagnosis in low-resourced health systems and in countries where stigma prevents people from getting tested.  
 
Read the full story: http://www.who.int/medicines/news/2017/1st_generic-hepC_1stHIVself-test-prequalified/en/
 
___________________________________
Daniela Bagozzi
Senior Information/Communication Manager
WHO/Essential Medicines and Health Products
E-mail: bagozzid at who.int
Tel. +41 22 791 19 90
Mob. +41 79 60 37 281 
http://www.who.int/medicines/en/
 




More information about the Ip-health mailing list